Search

The article discusses a study, published in a 2009 issue of "New England Journal of Medicine," which examined the use of endocrine therapy with zoledronic acid in improving disease-free survival of postmenopausal patients with early breast cancer.

This article presents the results of two studies that revealed the effect of socioeconomic or racial status on cancer care, conducted by the John Hopkins Hospital in Baltimore, Maryland and presented at the 2008 Breast Cancer Symposium. One study by Lisa K. Jacobs, an assistant professor of surgery at the hospital, looked at mastectomy rates for rural patients compared with women in urban areas. Another study by postdoctoral fellow Grace L. Smith investigated the impact of race on care for women with early stage breast cancer.

The article discusses research on the effectiveness of molecular breast imaging as screening method for women with dense breasts. It references a study presented by Carrie B. Hruska and colleagues at the 2008 Breast Cancer Symposium held in Washington, D.C. Researchers reportedly observed that molecular breast imaging was 75% more sensitive than mammography and 93% more specific. Also noted is a commentary on the study findings.

The article discusses research being done on the effectiveness of zoledronic acid in improving disease-free survival and relapse rate when added to endocrine therapy. It references a study by Michael Gnant from the Medical University of Vienna, Austria. Premonopausal women with stage I or II hormone-responsive breast cancer from 1999 to 2006 were involved in the study.